Alpha DNA Investment Management’s Onto Innovation ONTO Stock Holding History

Alpha DNA Investment Management’s Portfolio ONTO Stock Details ONTO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,137	Closed	-$444K	–	241
2024 Q3	$444K	Buy	2,137 +93	+5%	+$18.8K	0.17%	150
2024 Q2	$449K	Buy	+2,044	New	+$422K	0.17%	135
2022 Q2	–	Sell	-13,285	Closed	-$1.15M	–	154
2022 Q1	$1.15M	Sell	13,285 -1,964	-13%	-$175K	0.81%	89
2021 Q4	$1.54M	Sell	15,249 -4,063	-21%	-$351K	0.97%	59
2021 Q3	$1.39M	Sell	19,312 -869	-4%	-$62.7K	0.95%	62
2021 Q2	$1.47M	Buy	20,181 +9,410	+87%	+$647K	1.01%	45
2021 Q1	$707K	Buy	+10,771	New	+$641K	0.81%	34

Other funds holding ONTO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Alpha DNA Investment Management's ONTO Position: Q4 2024 in Review

Alpha DNA Investment Management sold out of Onto Innovation (ONTO) in Q4 2024, closing a stake of 2,137 shares — an estimated $444K sold.

Alpha DNA Investment Management first reported a position in ONTO in Q1 2021 and held it in 7 quarters. The position peaked at $1.54M in Q4 2021. 520 funds tracked by Wall St. Rank hold ONTO as of Q4 2024.

Alpha DNA Investment Management reported no remaining Onto Innovation position as of Q4 2024 after selling out during the quarter.
Alpha DNA Investment Management sold 2,137 Onto Innovation shares in Q4 2024, an estimated $444K.
Alpha DNA Investment Management first reported a position in Onto Innovation in Q1 2021 and held it in 7 quarters.
Alpha DNA Investment Management's Onto Innovation position peaked at $1.54M in Q4 2021.
520 funds tracked by Wall St. Rank held Onto Innovation as of Q4 2024.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.